2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment
Barreca, P.; Giannola, C.; Palisi, F.
Acta Europaea Fertilitatis 9(1): 21-29
1978
ISSN/ISBN: 0587-2421 PMID: 567920 Document Number: 131428
Document emailed within 1 workday
Related Documents
Rivadeneyra, J.; Barranco, M. 1974: Amenorrhea-galactorrhea and pituitary tumor (Forbes-Albright syndrome) induction of evaluation and pregnancy. Report of a case Ginecologia y Obstetricia de Mexico 36(213): 33-39Matsuda, M.; Hattori, T.; Tabata, K.; Seki, S. 1999: A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome Rinsho Shinkeigaku 39(11): 1160-1163
Young, R.L. 1978: The amenorrhea-galactorrhea syndrome Comprehensive Therapy 4(9): 40-45
Kurachi, K.; Aono, T. 1977: Galactorrhea-amenorrhea syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 1): 1156-1157
Arrata, W.S.; Howard, A. 1972: The amenorrhea-galactorrhea syndrome following oral contraceptives Journal of Reproductive Medicine 8(3): 139-142
Servy, E.; Greenblatt, R.B.; Scholer, H.F. 1970: The syndrome of amenorrhea, galactorrhea and low secretion of gonadotropins Bordeaux Medical 3(12): 2845-2848 Passim
Ge, Q.S. 1984: Hyperprolactinemia--its relation to galactorrhea, amenorrhea, pituitary tumor and its management Zhonghua Yi Xue Za Zhi 64(9): 545-549
Badawy, S.Z.; Nusbaum, M.L.; Omar, M. 1980: Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia Obstetrics and Gynecology 55(1): 1-7
Szücs, J.; Csillag, J. 1982: Alphamethyldopa-induced hyperprolactinemia, amenorrhea, galactorrhea syndrome in chronic kidney failure Orvosi Hetilap 123(20): 1241-1242
Pico, I.; Zárate, A.; Canales, E.S.; De la Cruz, A.; Jacobs, L.S.; Daughaday, W.H. 1973: Postpartum amenorrhea and galactorrhea syndrome associated with primary hypothyroidism. Functional study of the secretion of prolactin Ginecologia y Obstetricia de Mexico 33(197): 251-255
Takahashi, K.; Ikeno, N.; Minato, K.; Fukaya, T.; Momono, K.; Hoshiai, H.; Furuhashi, N. 1982: Prolactin releasing activity in serum of pregnant women and patients with galactorrhea-amenorrhea syndrome Nihon Sanka Fujinka Gakkai Zasshi 34(9): 1479-1486
Bol'shakova, T.D.; Buniatian, A.F.; Gitel', E.P.; Mel'nichenko, G.A.; Artiukhina, L.B. 1984: Prolactin, hydrocortisone and corticosterone content of the peripheral blood of patients with the galactorrhea-amenorrhea syndrome Problemy Endokrinologii 30(3): 15-18
Hartemann, P.; Leclere, J.; Groussin, M.; Valdenaire, J.C.; Maureira, J.J.; Belleville, F.; Nabet, P. 1977: Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases Journal de Gynecologie Obstetrique et Biologie de la Reproduction 6(4): 537-546
Godó, G.; Sas, M. 1980: The importance of the prolactin level in the development and treatment of amenorrhea-galactorrhea caused by hormonal contraceptives Orvosi Hetilap 121(18): 1059-1062
Maleeva, A.; Vulkov, I. 1977: Hypothalamo-hypophyseal-gonadal axis in the galactorrhea-amenorrhea syndrome with hypophyseal tumors and other endocrine disorders Akusherstvo i Ginekologiia 16(3): 182-190
Maleeva, A.; Vulkov, I. 1977: Hypothalamo-hypophyseal-gonadal axis in the galactorrhea-amenorrhea syndrome with hypophyseal tumors and other endocrine disorders Akusherstvo i Ginekologiia 16(3): 182-190
Rjosk, H.K.; Fahlbusch, R.; von Werder, K. 1980: Hyperprolactinemia as a frequent cause of amenorrhea and galactorrhea Medizinische Klinik 75(17): 609-612
Fenasse, R.; Mazet, M.; Serment, H. 1972: Etiology of amenorrhea-galactorrhea syndromes Revue Francaise de Gynecologie et d'Obstetrique 67(11): 625-631
Ladefoged, J. 1972: Non-puerperal galactorrhea, diabetes insipidus and amenorrhea Ugeskrift for Laeger 134(48): 2541-2542
Uras, R.; Orrù, M.; Pani, F.; Marotto, M.F.; Pilloni, M.; Guerriero, S.; Etzi, R.; Zedda, P.; Sorge, R.; Lello, S.; Melis, G.B.; Paoletti, A.M. 2010: Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome Contraception 82(2): 131-138